Literature DB >> 8227345

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

T Yokoyama1, L Vaca, R D Rossen, W Durante, P Hazarika, D L Mann.   

Abstract

To define the mechanism(s) responsible for the negative inotropic effects of tumor necrosis factor-alpha (TNF alpha) in the adult heart, we examined the functional effects of TNF alpha in the intact left ventricle and the isolated adult cardiac myocyte. Studies in both the ventricle and the isolated adult cardiac myocyte showed that TNF alpha exerted a concentration- and time-dependent negative inotropic effect that was fully reversible upon removal of this cytokine. Further, treatment with a neutralizing anti-TNF alpha antibody prevented the negative inotropic effects of TNF alpha in isolated myocytes. A cellular basis for the above findings was provided by studies which showed that treatment with TNF alpha resulted in decreased levels of peak intracellular calcium during the systolic contraction sequence; moreover, these findings did not appear to be secondary to alterations in the electrophysiological properties of the cardiac myocyte. Further studies showed that increased levels of nitric oxide, de novo protein synthesis, and metabolites of the arachidonic acid pathway were unlikely to be responsible for the TNF alpha-induced abnormalities in contractile function. Thus, these studies constitute the initial demonstration that the negative inotropic effects of TNF alpha are the direct result of alterations in intracellular calcium homeostasis in the adult cardiac myocyte.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227345      PMCID: PMC288411          DOI: 10.1172/JCI116834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses.

Authors:  T Gulick; S J Pieper; M A Murphy; L G Lange; G F Schreiner
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

Review 2.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

Authors:  J Vilcek; T H Lee
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

3.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 5.  Cytotoxic mechanism of tumor necrosis factor-alpha.

Authors:  J W Larrick; S C Wright
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

6.  Mediation of cardioprotection by transforming growth factor-beta.

Authors:  A M Lefer; P Tsao; N Aoki; M A Palladino
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

7.  Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells.

Authors:  P N Bouchelouche; K Bendtzen; S Bak; O H Nielsen
Journal:  Cell Signal       Date:  1990       Impact factor: 4.315

8.  A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine.

Authors:  E M Fenwick; A Marty; E Neher
Journal:  J Physiol       Date:  1982-10       Impact factor: 5.182

9.  Ultrastructure of terminally differentiated adult rat cardiac muscle cells in culture.

Authors:  R L Moses; W C Claycomb
Journal:  Am J Anat       Date:  1982-06

10.  Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium.

Authors:  D L Mann; Y Urabe; R L Kent; S Vinciguerra; G Cooper
Journal:  Circ Res       Date:  1991-02       Impact factor: 17.367

View more
  121 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The effect of cytokines on cardiac allograft function: tumor necrosis factor alpha a mediator of chronic injury.

Authors:  A Perez-Verdia; S J Stetson; S McRee; W Mazur; M M Koerner; G Torre-Amione
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 3.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 4.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

5.  Cardiomyopathy is linked to complement activation.

Authors:  Marina Afanasyeva; Noel R Rose
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 6.  Safety of biologic therapy in rheumatoid arthritis.

Authors:  Robert S Woodrick; Eric M Ruderman
Journal:  Nat Rev Rheumatol       Date:  2011-10-11       Impact factor: 20.543

7.  Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death.

Authors:  Tadashi Yoshida; Nitin A Das; Andrea J Carpenter; Reza Izadpanah; Senthil A Kumar; Sandeep Gautam; Shawn B Bender; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

8.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

9.  The multiple organ dysfunction syndrome and late-phase mortality in sepsis.

Authors:  Joshua A Englert; Mitchell P Fink
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

Review 10.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.